$14.21
0.151.07%
At close: Feb 12, 4:00 PM EST
$14.21
0.151.07%
Pre-Market: 4:05 AM EST
Comments
Loading...
Bicara Therapeutics Inc Earnings Estimates
BCAXNASDAQ
Bicara Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BCAX
Bicara Therapeutics (BCAX) is scheduled to report Q4 earnings on March 26, 2026. Analysts estimate EPS of $-0.68 and quarterly revenue of N/A.
In the most recent quarter (Q3), Bicara Therapeutics reported EPS of $-0.67, missing estimates of $-0.54 by 0.24%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Bicara Therapeutics has averaged an EPS surprise of 0.36% and a revenue surprise of 0.00%.
Earnings Date
Mar 26
EPS Estimate
$-0.680
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Bicara Therapeutics Earnings History
Analyze the earnings history of Bicara Therapeutics using advanced sorting and filters.
Bicara Therapeutics (BCAX) Earnings Per Share
The chart below shows Bicara Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-0.67 | $-0.54 | -24.1 % |
| Q2 | 2025-08-12 | $-0.50 | $-0.54 | 7.41 % |
| Q1 | 2025-05-13 | $-0.68 | $-0.38 | -79.0 % |
| Q4 | 2025-03-27 | $-0.39 | $-0.29 | -34.5 % |
Bicara Therapeutics (BCAX) Revenue
The chart below shows Bicara Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Bicara Therapeutics (NASDAQ:BCAX) reporting earnings?
Bicara Therapeutics (BCAX) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 10, 2025 for Q3.
What were the latest earnings per share (EPS) for Bicara Therapeutics (NASDAQ:BCAX)?
The Actual EPS was $-0.67, which missed the estimate of $-0.54.
What were Bicara Therapeutics’s (NASDAQ:BCAX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
